Skip to search formSkip to main contentSkip to account menu

BMS-986094

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Abstract β-D-2’-C-Methyl-2,6-diaminopurine ribonucleoside (2’-C-Me-DAPN) phosphoramidate prodrug (DAPN-PD) is a selective… 
2018
2018
A short and efficient synthesis of the nucleoside fragment contained in the NS5B nucleoside inhibitor BMS-986094 was achieved in… 
2017
2017
We read with interest the study by Welzel et al 1 confirming the high efficacy of oral direct-acting antiviral agents (DAAs) for… 
2016
2016
BMS-986094, the prodrug of a guanosine nucleotide analogue (2'-C-methylguanosine), was withdrawn from clinical trials due to… 
Review
2014
Review
2014
Introduction: About 150 million people worldwide are estimated to be chronically infected with the hepatitis C virus (HCV… 
2012
2012
1015 The BMS-986094 molecule, an inhibitor of the HCV RNA polymerase nonstructural protein 5B (NS5B), is an aryl-phosphoramidate…